Board of Directors

Russ Rhodes

Russ Rhodus is The President and Board Chair. He is accomplished at professional development and leading people to the successful completion of mission objectives. He is strong at taking projects from concept through delivery. He has worked as a consultant for The Center for Addiction Treatment, The Prospect House and OARS (Oconee Addiction & Recovery Services); Russ has his MBA from Xavier University with a concentration in Data Analytics and his B.S. degree in Operations Management from Wright State University.

John McLellan

John McLellan is the CEO of Harris House. He served as Executive Director of The Prospect House, Southwest Ohio’s leading long-term residential drug and alcohol treatment center for men. John has strong leadership skills and financial management experience. John has a Master's in Accounting from the University of Cincinnati and serves as the Treasurer on the Legacy Home of Recovery’s Board. 

Tammy Aiken-Clark

Since leaving Corporate America, Tammy Aiken-Clark has volunteered her available time to the nonprofit community of Pickens County. She brings to Legacy Home of Recovery years of experience in Corporate Management, Human Resources, Safety-Health-Environment, Children & Homeless Services and Festivals & Events. Tammy has served numerous nonprofit and business boards in the public and private sectors. By the Grace of God, she serves where HE plants her.

Karyn M. Dyehouse

Karyn M. Dyehouse, MD, is a physician specializing in medical oncology and hematology at the Prisma Health Cancer Institute. She provides general hematology and medical oncology with an emphasis on solid tumors such as breast, colon and lung cancer. Prior to her work at the Prisma Health Cancer Institute, she served as the Chief Medical Officer at Oncology Hematology Care in Cincinnati, Ohio.

Marc Birtwistle

Marc Birtwistle is a Professor of Chemical and Biomolecular Engineering at Clemson University. He received his bachelor's degree from the Georgia Institute of Technology (2003) and his Ph.D. from the University of Delaware (2008). He had postdoctoral training in Cell and Molecular Biology at the Beatson Institute for Cancer Research and University College Dublin (2011).